Schedule 13G ownership disclosure
Akers Biosciences Inc
Security class unavailable · CUSIP: 00973E102
Event date: 2018-02-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-18-009695
- Form type
- SC 13G
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Jul 26, 2018
- Reporting period
- Feb 05, 2018
- Description
- Schedule 13G beneficial ownership